Key result
Nutritional and metabolic support may improve critically ill HF outcomes, while glucose-insulin-potassium shows no benefit.
Why the study?
Does nutritional and metabolic support improve outcomes in critically ill patients with heart failure?
Population
Critically ill patients with heart failure in the intensive care unit
Design
Review
Authors
Loading...
Metabolic support merits evaluation in ICU HF; leaves open routine adoption pending randomized confirmation.
Does nutritional and metabolic support improve outcomes in critically ill patients with heart failure?
Nutritional and metabolic support, including tight glycemic control and addressing anabolic-catabolic imbalance, may be beneficial for critically ill heart failure patients, though glucose-insulin-potassium therapy is likely ineffective.
Meltzer et al. (2008) conducted a review in Heart failure in the intensive care unit. Nutritional and metabolic support was evaluated. Nutritional and metabolic support, including intensive insulin therapy and statins, may improve outcomes in critically ill heart failure patients, while glucose-insulin-potassium therapy likely does not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: